In particular, the largest trial investigating the effects of HF therapy guidance with repetitive NT-proBNP measurements, the GUIDE-IT trial, failed to demonstrate superiority of this approach over care as usual40. The gene discussed is NPPB; the disease is hydrops fetalis.